Carnitine synthesis and uptake into cells are stimulated by fasting in pigs as a model of nonproliferating species

Journal of Nutritional Biochemistry

Volumn 20, Issue 11, 2009, Pages 840-847

  Ringseis, Robert ^a   Wege, Nicole ^a   Wen, Gaiping ^a   Rauer, Christine ^a   Hirche, Frank ^a   Kluge, Holger ^a   Eder, Klaus ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Carnitine; Fasting; Novel organic cation transporter; Peroxisome proliferator activated receptor ; Pig

Indexed keywords

CARNITINE; CARNITINE PALMITOYLTRANSFERASE I; GAMMA BUTYROBETAINE DIOXYGENASE; MESSENGER RNA; ORGANIC CATION TRANSPORTER 2; PALMITOYL COENZYME A HYDROLASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

AMINO ACID SYNTHESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVITY; GENE ACTIVATION; HEART; KIDNEY PARENCHYMA; LIVER; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SMALL INTESTINE MUCOSA; SWINE; UPREGULATION;

ACYL-COA OXIDASE; ANIMALS; CARNITINE; CARNITINE O-PALMITOYLTRANSFERASE; FASTING; GAMMA-BUTYROBETAINE DIOXYGENASE; INTESTINAL MUCOSA; INTESTINE, SMALL; KIDNEY; LIVER; MALE; MUSCLE, SKELETAL; MYOCARDIUM; ORGANIC CATION TRANSPORT PROTEINS; PPAR ALPHA; RNA, MESSENGER; SWINE;

RODENTIA; SUIDAE;

EID: 71749092757     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2008.07.012     Document Type: Article

References (39)

1. McGarry J.D., and Brown N.F. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244 (1997) 1-14
2. Brass E.P. Pivalate-generating prodrugs and carnitine homeostasis in man. Pharmacol Rev 54 (2002) 589-598
3. Steiber A., Kerner J., and Hoppel C.L. Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med 25 (2004) 455-473
4. Rebouche C.J., and Seim H. Carnitine metabolism and its regulation in microorganisms and mammals. Annu Rev Nutr 18 (1998) 39-61
5. Vaz F.M., and Wanders R.J. Carnitine biosynthesis in mammals. Biochem J 361 (2002) 417-429
6. Lahjouji K., Mitchell G.A., and Qureshi I.A. Carnitine transport by organic cation transporters and systemic carnitine deficiency. Mol Genet Metab 73 (2001) 287-297
7. Tein I. Carnitine transport: pathophysiology and metabolism of known defects. J Inherit Metab Dis 26 (2003) 147-169
8. Tamai I., Ohashi R., Nezu J.I., Sai Y., Kobayashi D., Oku A., et al. Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem 275 (2000) 40064-40072
9. Tamai I., Ohashi R., Nezu J., Yabuuchi H., Oku A., Shimane M., et al. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 273 (1998) 20378-20382
10. Tamai I., Yabuuchi H., Nezu J., Sai Y., Oku A., Shimane M., et al. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 419 (1997) 107-111
11. Ohashi R., Tamai I., Nezu J., Nikaido H., Hashimoto N., Oku A., et al. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2. Mol Pharmacol 59 (2001) 358-366
12. +-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther 291 (1999) 778-784
13. Wu X., Huang W., Prasad P.D., Seth P., Rajan D.P., Leibach F.H., et al. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 290 (1999) 1482-1492
14. Slitt A.L., Cherrington N.J., Hartley D.P., Leazer M.T., and Klaassen C.D. Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels. Drug Metab Dispos 30 (2002) 212-219
15. van Vlies N., Ferdinandusse S., Turkenburg M., Wanders R.J., and Vaz F.M. PPARα-activation results in enhanced carnitine biosynthesis and OCTN2-mediated hepatic carnitine accumulation. Biochim Biophys Acta 1767 (2007) 1134-1142
16. Koch A., König B., Stangl G.I., and Eder K. PPARα mediates transcriptional upregulation of novel organic cation transporters-2 and -3 and enzymes involved in hepatic carnitine synthesis. Exp Biol Med (Maywood) 233 (2008) 356-365
17. Maeda T., Wakasawa T., Funabashi M., Fukushi A., Fujita M., Motojima K., et al. Regulation of Octn2 transporter (SLC22A5) by peroxisome proliferator activated receptor alpha. Biol Pharm Bull 31 (2008) 1230-1236
18. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocr Rev 20 (1999) 649-688
19. Mandard S., Müller M., and Kersten S. Peroxisome proliferator receptor α target genes. Cell Mol Life Sci. 61 (2004) 393-416
20. Brass E.P., and Hoppel C.L. Carnitine metabolism in the fasting rat. J Biol Chem 253 (1978) 2688-2693
21. Luci S., Hirche F., and Eder K. Fasting and caloric restriction increases mRNA concentrations of novel organic cation transporter-2 and carnitine concentrations in rat tissues. Ann Nutr Metab 52 (2008) 58-67
22. Luci S., Geissler S., König B., Koch A., Stangl G.I., Hirche F., et al. PPARα agonists up-regulate organic cation transporters in rat liver cells. Biochem Biophys Res Commun 24 (2006) 704-708
23. Peters J.M., Cheung C., and Gonzalez F.J. Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?. J Mol Med 83 (2005) 774-785
24. Holden P.R., and Tugwood J.D. Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences. J Mol Endocrinol 22 (1999) 1-8
25. Luci S., Giemsa B., Kluge H., and Eder K. Clofibrate causes an upregulation of PPARα target genes but does not alter expression of SREBP target genes in liver and adipose tissue of pigs. Am J Physiol Regul Integr Comp Physiol 293 (2007) R70-R77
26. National Research Council. Nutrient requirement of swine. Tenth Revised Edition (1998), National Academie of Sciences, Washington DC
27. Ringseis R., Pösel S., Hirche F., and Eder K. Treatment with pharmacological peroxisome proliferator-activated receptor α agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats. Pharmacol Res 56 (2007) 175-183
28. Van Vlies N., Wanders R.J., and Vaz F.M. Measurement of carnitine biosynthesis enzyme activities by tandem mass spectrometry: differences between the mouse and the rat. Anal Biochem 354 (2006) 132-139
29. Ringseis R., Saal D., Müller A., Steinhart H., and Eder K. Dietary conjugated linoleic acids lower the triacylglycerol concentration in the milk of lactating rats and impair the growth and increase the mortality of their suckling pups. J Nutr 134 (2004) 3327-3334
30. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., and Wahli W. Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting. J Clin Invest 103 (1999) 1489-1498
31. Li R.Y., Zhang Q.H., Liu Z., Qiao J., Zhao S.X., Shao L., et al. Effect of short-term and long-term fasting on transcriptional regulation of metabolic genes in rat tissues. Biochem Biophys Res Commun 344 (2006) 562-570
32. Cheon Y., Nara T.Y., Band M.R., Beever J.E., Wallig M.A., and Nakamura M.T. Induction of overlapping genes by fasting and a peroxisome proliferator in pigs: evidence of functional PPARalpha in nonproliferating species. Am J Physiol Regul Integr Comp Physiol 288 (2005) R1525-R1535
33. Rebouche C.J., Bosch E.P., Chenard C.A., Schabold K.J., and Nelson S.E. Utilization of dietary precursors for carnitine synthesis in human adults. J Nutr 119 (1989) 1907-1913
34. Brandt J.M., Djouadi F., and Kelly D. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha. J Biol Chem 273 (1998) 23786-23792
35. Kato Y., Sugiura M., Sugiura T., Wakayama T., Kubo Y., Kobayashi D., et al. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse. Mol Pharmacol 70 (2006) 829-837
36. Koepsell H., and Endou H. The SLC22 drug transporter family. Pflugers Arch 447 (2004) 666-676
37. Lahjouji K., Elimrani I., Lafond J., Leduc L., Qureshi I.A., and Mitchell G.A. l-Carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2. Am J Physiol Cell Physiol 287 (2004) C263-C269
38. Grube M., Meyer zu Schwabedissen H.E., Präger D., Haney J., Möritz K.U., Meissner K., et al. Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5). Circulation 113 (2006) 1114-1122
39. Hirano T., Yasuda S., Osaka Y., Kobayashi M., Itagaki S., and Iseki K. Mechanism of the inhibitory effect of zwitterionic drugs (levofloxacin and grepafloxacin) on carnitine transporter (OCTN2) in Caco-2 cells. Biochim Biophys Acta 1758 (2006) 1743-1750